- Record: found
- Abstract: found
- Article: not found
Phase II study of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemia.
Sima Jeha
1 ,
Bassem Razzouk ,
Michael Rytting ,
Susan Rheingold ,
Edythe Albano ,
Richard Kadota ,
Lori Luchtman-Jones ,
Lisa Bomgaars ,
Paul Gaynon ,
Stewart Goldman ,
Kim Ritchey ,
Robert Arceci ,
Arnold Altman ,
Kimo Stine ,
Laurel Steinherz ,
Peter Steinherz
Sep 10 2009
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To determine the efficacy and safety of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemia (AML).